Variable within- and between-herd diversity of CTX-M cephalosporinase-bearing Escherichia coli isolates from dairy cattle

Applied and Environmental Microbiology

Volumn 78, Issue 13, 2012, Pages 4552-4560

  Mollenkopf, Dixie F ^a   Weeman, Matthew F ^a   Daniels, Joshua B ^a   Abley, Melanie J ^a   Mathews, Jennifer L ^a   Gebreyes, Wondwossen A ^a   Wittum, Thomas E ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ISOLATES; DAIRY CATTLES; DAIRY FARMS; E. COLI; FECAL SAMPLES; GENETIC DIVERSITY; PLASMID INCOMPATIBILITY; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISMS; SALMONELLA SPP;

AGRICULTURE; ANTIBIOTICS; DNA; DNA SEQUENCES; ELECTROPHORESIS; ESCHERICHIA COLI; RECOVERY; SEWAGE TREATMENT PLANTS;

GENES;

ANTIINFECTIVE AGENT; CEFTIOFUR; CEPHALOSPORIN DERIVATIVE; CEPHALOSPORINASE;

ALLELE; ANTIBIOTIC RESISTANCE; CATTLE; COLIFORM BACTERIUM; DATA ACQUISITION; ENZYME ACTIVITY; FECES; GENE EXPRESSION; GENE TRANSFER; GENETIC ANALYSIS; GENETIC MARKER; GENETIC VARIATION; PLASMID; SPECIES DIVERSITY;

ANIMAL; ARTICLE; BACTERIUM IDENTIFICATION; BIOSYNTHESIS; CATTLE; CLASSIFICATION; CLUSTER ANALYSIS; DNA FINGERPRINTING; DRUG UTILIZATION; ENZYMOLOGY; ESCHERICHIA COLI; FECES; GENETIC VARIABILITY; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MICROBIOLOGY; PLASMID; PULSED FIELD GEL ELECTROPHORESIS; SALMONELLA; STATISTICS; UNITED STATES;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CATTLE; CEPHALOSPORINASE; CEPHALOSPORINS; CLUSTER ANALYSIS; DNA FINGERPRINTING; DRUG UTILIZATION; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; FECES; GENETIC VARIATION; GENOTYPE; OHIO; PLASMIDS; SALMONELLA;

OHIO; UNITED STATES;

BACTERIA (MICROORGANISMS); BOS; ESCHERICHIA COLI; SALMONELLA;

EID: 84864112741     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.00373-12     Document Type: Article

References (53)

1. Bayardelle P, Zafarullah M. 2002. Development of oligonucleotide primers for the specific PCR-based detection of the most frequent Enterobacteriaceae species DNA using wec gene templates. Can. J. Microbiol. 48: 113-122.
2. Call DR, et al. 2010. blaCMY-2-positive IncA/C plasmids from Escherichia coli and Salmonella enterica are a distinct component of a larger lineage of plasmids. Antimicrob. Agents Chemother. 54:590-596.
3. Carattoli A. 2009. Resistance plasmid families in Enterobacteriaceae. Antimicrob. Agents Chemother. 53:2227-2238.
4. Carattoli A, et al. 2005. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods 63:219-228.
5. Carattoli A, et al. 2006. Replicon typing of plasmids encoding resistance to newer beta-lactams. Emerg. Infect. Dis. 12:1145-1148.
6. Cavaco LM, Abatih E, Aarestrup FM, Guardabassi L. 2008. Selection and persistence of CTX-M-producing Escherichia coli in the intestinal flora of pigs treated with amoxicillin, ceftiofur, or cefquinome. Antimicrob. Agents Chemother. 52:3612-3616.
7. Centers for Disease Control and Prevention (ed). 1996 (updated 2000). Standardized molecular subtyping of foodborne bacterial pathogens by pulsed-field gel electrophoresis: a manual. National Center for Infectious Diseases, Atlanta, GA.
8. Clinical and Laboratory Standards Institute. 2008. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 8th ed. CLSI document M07-A8. CLSI, Wayne, PA.
9. Costa D, et al. 2006. Detection of Escherichia coli harbouring extendedspectrum beta-lactamases of the CTX-M, TEM and SHV classes in faecal samples of wild animals in Portugal. J. Antimicrob. Chemother. 58:1311-1312.
10. Daniels JB, et al. 2009. Role of ceftiofur in selection and dissemination of blaCMY-2-mediated cephalosporin resistance in Salmonella enterica and commensal Escherichia coli isolates from cattle. Appl. Environ. Microbiol. 75:3648-3655.
11. Doi Y, et al. 2010. Extended-spectrum and CMY-type beta-lactamaseproducing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain. Clin. Microbiol. Infect. 16:33-38.
12. Dolejska M, et al. 2011. IncN plasmids carrying blaCTX-M-1 in Escherichia coli isolates on a dairy farm. Vet. Microbiol. 149:513-516.
13. GarcíA-Fernández A, et al. 2011. Multilocus sequence typing of IncN plasmids. J. Antimicrob. Chemother. 66:1987-1991.
14. Gebreyes WA, Thakur S. 2005. Multidrug-resistant Salmonella enterica serovar Muenchen from pigs and humans and potential interserovar transfer of antimicrobial resistance. Antimicrob. Agents Chemother. 49: 503-511.
15. Hawkey PM, Jones AM. 2009. The changing epidemiology of resistance. J. Antimicrob. Chemother. 64:i3-i10.
16. Heider LC, et al. 2009. Identification of Escherichia coli and Salmonella enterica organisms with reduced susceptibility to ceftriaxone from fecal samples of cows in dairy herds. Am. J. Vet. Res. 70:389-393.
17. Horton R, et al. 2011. Faecal carriage and shedding density of CTX-M ESBL Escherichia coli in cattle, chickens, and pigs: implications for environmental contamination and food production. Appl. Environ. Microbiol. 77:3715-3719.
18. Jacoby GA, Archer GL. 1991. New mechanisms of bacterial resistance to antimicrobial agents. N. Engl. J. Med. 324:601-612.
19. Jiang XP, Yang H, Dettman B, Doyle MP. 2006. Analysis of fecal microbial flora for antibiotic resistance in ceftiofur-treated calves. Foodborne Pathog. Dis. 3:355-365.
20. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. 2010. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin. Infect. Dis. 51:286-294.
21. Johnson JR, Kuskowski MA, Gajewski A, Sahm DF, Karlowsky JA. 2004. Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000-2001. J. Infect. Dis. 190: 1739-1744.
22. Johnson JR, Miller S, Johnston B, Clabots C, Debroy C. 2009. Sharing of Escherichia coli sequence type ST131 and other multidrug-resistant and urovirulent E. coli strains among dogs and cats within a household. J. Clin. Microbiol. 47:3721-3725.
23. Jørgensen CJ, Cavaco LM, Hasman H, Emborg HD, Guardabassi L. 2007. Occurrence of CTX-M-1-producing Escherichia coli in pigs treated with ceftiofur. J. Antimicrob. Chemother. 59:1040-1042.
24. Kado C, Liu S. 1981. Rapid procedure for detection and isolation of large and small plasmids. J. Bacteriol. 145:1365-1373.
25. Koeck JL, et al. 1997. A plasmid-mediated CMY-2 β-lactamase from an Algerian clinical isolate of Salmonella senftenberg. FEMS Microbiol. Lett. 152:255-260.
26. Lewis JS, II, Herrera M, Wickes B, Patterson JE, Jorgensen JH. 2007. First report of the emergence of CTX-M-type extended-spectrum betalactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Antimicrob. Agents Chemother. 51:4015-4021.
27. Liebana E, et al. 2006. Longitudinal farm study of extended-spectrum beta-lactamase-mediated resistance. J. Clin. Microbiol. 44:1630-1634.
28. Lowrance TC, et al. 2007. Changes in antimicrobial susceptibility in a population of Escherichia coli isolated from feedlot cattle administered ceftiofur crystalline-free acid. Am. J. Vet. Res. 68:501-507.
29. Ma L, et al. 2005. Variety of TEM-, SHV-, and CTX-M-type betalactamases present in recent clinical isolates of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae from Taiwan. Microb. Drug Resist. 11:31-39.
30. Mann S, Siler JD, Jordan D, Warnick LD. 2011. Antimicrobial susceptibility of fecal Escherichia coli isolates in dairy cows following systemic treatment with ceftiofur or penicillin. Foodborne Pathog. Dis. 8:861-867.
31. Mollenkopf DF, Kleinhenz KE, Funk JA, Gebreyes WA, Wittum TE. 2011. Salmonella enterica and Escherichia coli harboring blaCMY in retail beef and pork products. Foodborne Pathog. Dis. 8:333-336.
32. Mulvey MR, Susky E, McCracken M, Morck DW, Read RR. 2009. Similar cefoxitin-resistance plasmids circulating in Escherichia coli from human and animal sources. Vet. Microbiol. 134:279-287.
33. Naseer U, Sundsfjord A. 2011. The CTX-M conundrum: dissemination of plasmids and Escherichia coli clones. Microb. Drug Resist. 17:83-97.
34. O'Keefe A, Hutton TA, Schifferli DM, Rankin SC. 2010. First detection of CTX-M and SHV extended-spectrum _-lactamases in Escherichia coli urinary tract isolates from dogs and cats in the United States. Antimicrob. Agents Chemother. 54:3489-3492.
35. Pitout JDD, Gregson DB, Campbell L, Laupland KB. 2009. Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of communityacquired infections. Antimicrob. Agents Chemother. 53:2846-2851.
36. Radhouani H, et al. 2010. Detection of Escherichia coli harbouring extended-spectrum _-lactamases of the CTX-M classes in faecal samples of common buzzards (Buteo buteo). J. Antimicrob. Chemother. 65:171-173.
37. Ribot EM, et al. 2006. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157: H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog. Dis. 3:59-67.
38. Rodríguez-Baño J, et al. 2009. Escherichia coli producing SHV-type extended-spectrum _-lactamase is a significant cause of communityacquired infection. J. Antimicrob. Chemother. 63:781-784.
39. Rondon MR, Raffel SJ, Goodman RM, Handelsman J. 1999. Toward functional genomics in bacteria: analysis of gene expression in Escherichia coli from a bacterial artificial chromosome library of Bacillus cereus. Proc. Natl. Acad. Sci. U. S. A. 96:6451-6455.
40. Rossolini GM, D'Andrea MM, Mugnaioli C. 2008. The spread of CTXM-type extended-spectrum beta-lactamases. Clin. Microbiol. Infect. 14(Suppl 1):33-41.
41. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning: a laboratory manual, 2nd ed, p 2.82-2.98. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
42. Singer RS, Patterson SK, Wallace RL. 2008. Effects of therapeutic ceftiofur administration to dairy cattle on Escherichia coli dynamics in the intestinal tract. Appl. Environ. Microbiol. 74:6956-6962.
43. Siu L, et al. 2000. Beta-lactamases in Shigella flexneri isolates from Hong Kong and Shanghai and a novel OXA-1-like beta-lactamase, OXA-30. Antimicrob. Agents Chemother. 44:2034-2038.
44. Smet A, et al. 2008. Diversity of extended-spectrum β-lactamases and class C β-lactamases among cloacal Escherichia coli isolates in Belgian broiler farms. Antimicrob. Agents Chemother. 52:1238-1243.
45. Tenover FC, et al. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
46. Tian GB, et al. 2009. Detection of CTX-M-15, CTX-M-22, and SHV-2 extended-spectrum beta-lactamases (ESBLs) in Escherichia coli fecal-sample isolates from pig farms in China. Foodborne Pathog. Dis. 6:297-304.
47. Tragesser LA, Wittum TE, Funk JA, Winokur PL, Rajala-Schultz PJ. 2006. Association between ceftiofur use and isolation of Escherichia coli with reduced susceptibility to ceftriaxone from fecal samples of dairy cows. Am. J. Vet. Res. 67:1696-1700.
48. Walther-Rasmussen J, Hoiby N. 2004. Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum beta-lactamases. Can. J. Microbiol. 50:137-165.
49. Watson E, et al. 2012. Epidemiology of extended spectrum betalactamase E. coli (CTX-M-15) on a commercial dairy farm. Vet. Microbiol. 154:339-346.
50. Winokur PL, Vonstein DL, Hoffman LJ, Uhlenhopp EK, Doern GV. 2001. Evidence for transfer of CMY-2 AmpC beta-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans. Antimicrob. Agents Chemother. 45:2716-2722.
51. Wirth T, et al. 2006. Sex and virulence in Escherichia coli: an evolutionary perspective. Mol. Microbiol. 60:1136-1151.
52. Wittum TE, et al. 2010. CTX-M-type extended-spectrum β-lactamases present in Escherichia coli from the feces of cattle in Ohio, United States. Foodborne Pathog. Dis. 7:1575-1579.
53. World Health Organization. 2007. Critically important antimicrobials for human medicine: categorization for the development of risk management strategies to contain antimicrobial resistance due to non-human antimicrobial use. Report of the 2ndWHOExpert Meeting (Copenhagen, Denmark), 29 to 31 May 2007. WHO, Geneva, Switzerland.